Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
TENX
TENX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TENX News
Tenax Therapeutics (TENX) Price Target Raised by 12.22% to 25.76
Dec 21 2025
NASDAQ.COM
Tenax Initiates Global LEVEL-2 Study, Enrollment Expected by 2027
Dec 17 2025
Newsfilter
Tenax Initiates Global LEVEL-2 Study, Enrollment Expected by 2027
Dec 17 2025
Globenewswire
Tenax Therapeutics: Overview of Q3 Earnings
Nov 12 2025
Yahoo Finance
Tenax Therapeutics: Q2 Earnings Snapshot
Aug 13 2025
Yahoo Finance
Teanx Therapeutics plans secondary offering
Apr 16 2025
SeekingAlpha
Tenax Therapeutics files to sell 4.14M shares of common stock for holders
Apr 15 2025
Business Insider
Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Mar 25 2025
Newsfilter
Tenax Therapeutics Appoints Interim CFO Thomas McGauley
Dec 04 2024
Business Insider
Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors
Nov 04 2024
PRnewswire
This Sempra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Oct 24 2024
Benzinga
TENX Stock Earnings: Tenax Therapeutics Beats EPS for Q2 2024
Aug 14 2024
Business Insider
Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement
Aug 06 2024
Newsfilter
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Apr 18 2024
Business Insider
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Apr 18 2024
Benzinga
Tenax Therapeutics to Host KOL Event: "LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study"
Apr 09 2024
newsfilter
Show More News
